Managing nociception during surgery is a major challenge, impacting patient outcomes, length of stay and cost of treatment.
Excessive use of opioids may result in intraoperative hypotension, respiratory depression, PONV etc.,1,2,3 and underuse of analgesics may promote acute or chronic post-operative pain, delayed recovery and the costs associated with these complications.4,5,6
The PMD-200TM nociception monitor, developed by Medasense Ltd., helps you monitor your anaesthetized patients' physiological pain response (nociception) to noxious stimuli and tailor analgesic medications to each patient’s specific sensitivity and needs. The integrated nociception level index (NOL®) provides superior indication of the presence and severity of pain response vs. individual parameters (such as changes in heart rate and blood pressure) to reduce complications and improve patient outcomes.7,8
1. ACQUIRE → 2. ANALYZE → 3. QUANTIFY → 4. OPTIMAL PAIN CARE
The non-invasive platform continuously acquires physicological signals through 4 sensors. Dozens of physiological parameters and derivatives are extracted
Advanced articificial intelligence algorithms identify the pain-related pattern
The information is quantified and visualized with the NOL® index on a scale of 0 (no nociceptive response) to 100 (extreme nociceptive response)
NOL® guides clinicians to ensure optimal pain control while avoiding overmedication
By optimizing analgesic administration in critical care, NOL®-guided analgesia might enhance the patient experience as it reduces the risk of excessive use or underuse of opioids and associated complications.9